American journal of therapeutics最新文献

筛选
英文 中文
Endoscopy Sedation Challenges in Patients With Hepatic Encephalopathy: A Focused Review on Propofol and Selective Use of Benzodiazepines. 肝性脑病患者的内镜镇静挑战:异丙酚和选择性使用苯二氮卓类药物的重点综述。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-03-18 DOI: 10.1097/MJT.0000000000001926
Miruna V Moraru, Sandica Bucurica, Benjamin N A Proske, Smaranda Stoleru, Aurelian Zugravu, Oana A Coman, Ion Fulga
{"title":"Endoscopy Sedation Challenges in Patients With Hepatic Encephalopathy: A Focused Review on Propofol and Selective Use of Benzodiazepines.","authors":"Miruna V Moraru, Sandica Bucurica, Benjamin N A Proske, Smaranda Stoleru, Aurelian Zugravu, Oana A Coman, Ion Fulga","doi":"10.1097/MJT.0000000000001926","DOIUrl":"10.1097/MJT.0000000000001926","url":null,"abstract":"<p><strong>Background: </strong>Hepatic encephalopathy (HE) presents a significant challenge in gastrointestinal endoscopy sedation due to impaired liver function, which alters drug metabolism and increases the risk of adverse effects. In the absence of clear guidelines and specific biomarkers for diagnosis and assessment of HE, there is insufficient evidence to formulate standardized protocols for management, diagnosis, and sedation during endoscopy.</p><p><strong>Areas of uncertainty: </strong>Rigid protocols for sedation are difficult to implement due to wide variation in patient age, comorbidities, and disease severity, which creates a \"gray zone.\" This leaves decisions heavily reliant on the clinician's preference or experience, patient characteristics, and institutional protocols. This review highlights the strengths and limitations of propofol, midazolam, and remimazolam in efforts to improve sedation strategies for endoscopic procedures in patients with HE.</p><p><strong>Data sources: </strong>A review was conducted using PubMed and Scopus databases, keeping in view recent publications. Only primary research studies were considered for this review. Inclusion was based on the relevance of patient side effects, sedation outcomes, and safety profiles, with a particular focus on gastrointestinal endoscopy procedures and their implications in HE.</p><p><strong>Results: </strong>Propofol remains preferred in patients with HE, demonstrating manageable cardiovascular and respiratory events without worsening encephalopathy. However, its safety requires careful consideration in this high-risk population. The combination of propofol with adjuncts, such as esketamine, has shown potential in mitigating adverse effects and optimizing sedation protocols in challenging cases. Midazolam, though historically used, is not recommended in HE due to exacerbation of encephalopathy and unfavorable safety profiles. While remimazolam shows promise, no evidence in HE populations precludes definitive conclusions about its efficacy and safety.</p><p><strong>Conclusions: </strong>Future research should focus on optimizing sedation protocols according to the needs of HE patients, including tools for risk stratification and guidelines considering individual patient profiles. Furthermore, studies must be performed to evaluate remimazolam's outcomes and safety profiles, both as a standalone sedative and in combination with other agents.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143646789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frailty and Cardiovascular Comorbidities as Predictors of Short-Term Outcomes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Mildly Reduced Ejection Fraction Patients: Therapeutic Implications. 虚弱和心血管合并症作为保留射血分数的心力衰竭和轻度降低射血分数的心力衰竭患者短期预后的预测因素:治疗意义
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-03-04 DOI: 10.1097/MJT.0000000000001910
Georgios Tournas Androulakis, Christos Kourek, Argyro Papadopoulou, Eleni Sertedaki, Alexandros Briasoulis
{"title":"Frailty and Cardiovascular Comorbidities as Predictors of Short-Term Outcomes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Mildly Reduced Ejection Fraction Patients: Therapeutic Implications.","authors":"Georgios Tournas Androulakis, Christos Kourek, Argyro Papadopoulou, Eleni Sertedaki, Alexandros Briasoulis","doi":"10.1097/MJT.0000000000001910","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001910","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143539966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Euglycemic Diabetic Ketoacidosis in a Patient Treated With Empagliflozin After Acute Myocardial Infraction. 急性心肌梗死后应用恩格列净治疗的糖尿病患者酮症酸中毒。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-02-28 DOI: 10.1097/MJT.0000000000001907
George Tournas, Argyro Papadopoulou, Polyxeni Manifava, Maria Eirini Tselegkidi, Anna Dimoula, Panagiotis Nastatos, Eleftheria Tsagalou, Alexandros Briasoulis, Kimon Stamatelopoulos
{"title":"Euglycemic Diabetic Ketoacidosis in a Patient Treated With Empagliflozin After Acute Myocardial Infraction.","authors":"George Tournas, Argyro Papadopoulou, Polyxeni Manifava, Maria Eirini Tselegkidi, Anna Dimoula, Panagiotis Nastatos, Eleftheria Tsagalou, Alexandros Briasoulis, Kimon Stamatelopoulos","doi":"10.1097/MJT.0000000000001907","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001907","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143527828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Pharmacology Insights Into Nephrotic Syndrome: A Retrospective Analysis of Pathological Types and Drug Therapy Outcomes. 临床药理学洞察肾病综合征:病理类型和药物治疗结果的回顾性分析。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-02-26 DOI: 10.1097/MJT.0000000000001908
Xi-Jie Zheng, Yang Xu, Jing Chen, Yan-Li Gou, Ya-Pu Zhang, Shan-Shan Guo, Hang Chen
{"title":"Clinical Pharmacology Insights Into Nephrotic Syndrome: A Retrospective Analysis of Pathological Types and Drug Therapy Outcomes.","authors":"Xi-Jie Zheng, Yang Xu, Jing Chen, Yan-Li Gou, Ya-Pu Zhang, Shan-Shan Guo, Hang Chen","doi":"10.1097/MJT.0000000000001908","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001908","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143497845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Farnesoid X Receptor Agonist in Patients With NAFLD: A Meta-Analysis of Metabolic Benefit and Risk. Farnesoid X受体激动剂在NAFLD患者中的应用:代谢获益和风险的荟萃分析。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-02-18 DOI: 10.1097/MJT.0000000000001874
Yumeng Wang, Xintian Shou, Ping Zhang, Boda Zhou
{"title":"Farnesoid X Receptor Agonist in Patients With NAFLD: A Meta-Analysis of Metabolic Benefit and Risk.","authors":"Yumeng Wang, Xintian Shou, Ping Zhang, Boda Zhou","doi":"10.1097/MJT.0000000000001874","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001874","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143439293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abrocitinib in the Treatment of Drug Reaction With Eosinophilia and Systemic Symptoms. 阿布替尼治疗嗜酸性粒细胞增多和全身症状的药物反应。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-02-13 DOI: 10.1097/MJT.0000000000001865
ZhiQin Zhang, Juan Liu, Di Wu, WeiLing Sun, ZhiQiang Yin
{"title":"Abrocitinib in the Treatment of Drug Reaction With Eosinophilia and Systemic Symptoms.","authors":"ZhiQin Zhang, Juan Liu, Di Wu, WeiLing Sun, ZhiQiang Yin","doi":"10.1097/MJT.0000000000001865","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001865","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a Combination Regimen of Jiawei Dachengqi Decoction and Shutaiqing on Intestinal Cleanness and Polyp Detection Rate. 加味大承气汤联合舒替清对肠道清洁度及息肉检出率的影响。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-02-13 DOI: 10.1097/MJT.0000000000001915
Xiuqin Fan, Weiwei Wang, Jiayan Shen, Lulu Xia, Yunjie Qi, Hongshi Wang
{"title":"Impact of a Combination Regimen of Jiawei Dachengqi Decoction and Shutaiqing on Intestinal Cleanness and Polyp Detection Rate.","authors":"Xiuqin Fan, Weiwei Wang, Jiayan Shen, Lulu Xia, Yunjie Qi, Hongshi Wang","doi":"10.1097/MJT.0000000000001915","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001915","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should We Intervene Early in Asymptomatic Aortic Stenosis? Evidence From a Meta-Analysis. 无症状主动脉瓣狭窄应该早期干预吗?来自元分析的证据。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-02-07 DOI: 10.1097/MJT.0000000000001881
Saad Ahmed Waqas, Muhammad Saad, Haiqa Aamer, Muhammad Umer Sohail, Muhammad Rashid, Raheel Ahmed
{"title":"Should We Intervene Early in Asymptomatic Aortic Stenosis? Evidence From a Meta-Analysis.","authors":"Saad Ahmed Waqas, Muhammad Saad, Haiqa Aamer, Muhammad Umer Sohail, Muhammad Rashid, Raheel Ahmed","doi":"10.1097/MJT.0000000000001881","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001881","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143370140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Protamine in Heparin Reversal After Transcatheter Aortic Valve Replacement. 鱼精蛋白在经导管主动脉瓣置换术后肝素逆转中的安全性和有效性。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-02-07 DOI: 10.1097/MJT.0000000000001901
Saad Ahmed Waqas, Muhammad Khalid Afridi, Taimor Mohammed Khan
{"title":"Safety and Efficacy of Protamine in Heparin Reversal After Transcatheter Aortic Valve Replacement.","authors":"Saad Ahmed Waqas, Muhammad Khalid Afridi, Taimor Mohammed Khan","doi":"10.1097/MJT.0000000000001901","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001901","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143370138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychopharmacology of Apathy. 冷漠的精神药理学。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-02-07 DOI: 10.1097/MJT.0000000000001860
Ahmed Naguy, Dalaal S Alablani, Noor Jassim Alsalem, Bibi Alamiri
{"title":"Psychopharmacology of Apathy.","authors":"Ahmed Naguy, Dalaal S Alablani, Noor Jassim Alsalem, Bibi Alamiri","doi":"10.1097/MJT.0000000000001860","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001860","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143370191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信